Identification and optimization of tetrahydro-2H-3-benzazepin-2-ones as squalene synthase inhibitors
Novel squalene synthase inhibitors are disclosed. SAR and pharmacological profile of selected compounds are discussed.
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry letters 2011-04, Vol.21 (8), p.2554-2558 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2558 |
---|---|
container_issue | 8 |
container_start_page | 2554 |
container_title | Bioorganic & medicinal chemistry letters |
container_volume | 21 |
creator | Griebenow, Nils Flessner, Timo Buchmueller, Anja Raabe, Martin Bischoff, Hilmar Kolkhof, Peter |
description | Novel squalene synthase inhibitors are disclosed. SAR and pharmacological profile of selected compounds are discussed. |
doi_str_mv | 10.1016/j.bmcl.2011.02.004 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_872139831</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>860179012</sourcerecordid><originalsourceid>FETCH-LOGICAL-c454t-5b1d75a3331e9a743631f087951eb3aa0c609b7bd082142963479d8a747710ad3</originalsourceid><addsrcrecordid>eNqF0cFu1DAQBmALUdGl8AIcIBfEyWHGduL4iKpCK1XqoVTiZk0Sh_Uqsbd29rD79M1qFzhysjT6Zkaen7EPCCUC1l83ZTt1YykAsQRRAqhXbIWqVlwqqF6zFZgaeGPUr0v2NucNACpQ6g27FChN3WC1Yv1d78LsB9_R7GMoKPRF3M5-8odTIQ7F7OZE632fIhe3XPLWhQMd3NYHLngMLheUi_y8o9EFV-R9mNeUXeHD2rd-jim_YxcDjdm9P79X7On7zc_rW37_8OPu-ts971SlZl612OuKpJToDGkla4kDNNpU6FpJBF0NptVtD41AJUwtlTZ9s0itEaiXV-zLae42xeedy7OdfO7cOFJwcZdto48fbyT-X9aA2gCKRYqT7FLMObnBbpOfKO0tgj3GYDf2GIM9xmBB2CWGpenjefyunVz_t-XP3Rfw-QwodzQOiULn8z-nwCAiLO7TyQ0ULf1Oi3l6XDZVS5ZS1UbLF3udme4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>860179012</pqid></control><display><type>article</type><title>Identification and optimization of tetrahydro-2H-3-benzazepin-2-ones as squalene synthase inhibitors</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Griebenow, Nils ; Flessner, Timo ; Buchmueller, Anja ; Raabe, Martin ; Bischoff, Hilmar ; Kolkhof, Peter</creator><creatorcontrib>Griebenow, Nils ; Flessner, Timo ; Buchmueller, Anja ; Raabe, Martin ; Bischoff, Hilmar ; Kolkhof, Peter</creatorcontrib><description>Novel squalene synthase inhibitors are disclosed. SAR and pharmacological profile of selected compounds are discussed.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2011.02.004</identifier><identifier>PMID: 21396815</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ltd</publisher><subject>alkyl (aryl) transferases ; Animals ; Benzazepines - chemical synthesis ; Benzazepines - chemistry ; Benzazepines - pharmacokinetics ; Biological and medical sciences ; Crystallography, X-Ray ; enzyme inhibitors ; Enzyme Inhibitors - chemical synthesis ; Enzyme Inhibitors - chemistry ; Enzyme Inhibitors - pharmacokinetics ; Farnesyl-Diphosphate Farnesyltransferase - antagonists & inhibitors ; Farnesyl-Diphosphate Farnesyltransferase - metabolism ; General and cellular metabolism. Vitamins ; heterocyclic compounds ; Humans ; Medical sciences ; Mice ; Microsomes, Liver - metabolism ; Molecular Conformation ; Pharmacology. Drug treatments ; Stereoisomerism ; Structure-Activity Relationship ; structure-activity relationships</subject><ispartof>Bioorganic & medicinal chemistry letters, 2011-04, Vol.21 (8), p.2554-2558</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c454t-5b1d75a3331e9a743631f087951eb3aa0c609b7bd082142963479d8a747710ad3</citedby><cites>FETCH-LOGICAL-c454t-5b1d75a3331e9a743631f087951eb3aa0c609b7bd082142963479d8a747710ad3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24091110$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21396815$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Griebenow, Nils</creatorcontrib><creatorcontrib>Flessner, Timo</creatorcontrib><creatorcontrib>Buchmueller, Anja</creatorcontrib><creatorcontrib>Raabe, Martin</creatorcontrib><creatorcontrib>Bischoff, Hilmar</creatorcontrib><creatorcontrib>Kolkhof, Peter</creatorcontrib><title>Identification and optimization of tetrahydro-2H-3-benzazepin-2-ones as squalene synthase inhibitors</title><title>Bioorganic & medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>Novel squalene synthase inhibitors are disclosed. SAR and pharmacological profile of selected compounds are discussed.</description><subject>alkyl (aryl) transferases</subject><subject>Animals</subject><subject>Benzazepines - chemical synthesis</subject><subject>Benzazepines - chemistry</subject><subject>Benzazepines - pharmacokinetics</subject><subject>Biological and medical sciences</subject><subject>Crystallography, X-Ray</subject><subject>enzyme inhibitors</subject><subject>Enzyme Inhibitors - chemical synthesis</subject><subject>Enzyme Inhibitors - chemistry</subject><subject>Enzyme Inhibitors - pharmacokinetics</subject><subject>Farnesyl-Diphosphate Farnesyltransferase - antagonists & inhibitors</subject><subject>Farnesyl-Diphosphate Farnesyltransferase - metabolism</subject><subject>General and cellular metabolism. Vitamins</subject><subject>heterocyclic compounds</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Microsomes, Liver - metabolism</subject><subject>Molecular Conformation</subject><subject>Pharmacology. Drug treatments</subject><subject>Stereoisomerism</subject><subject>Structure-Activity Relationship</subject><subject>structure-activity relationships</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0cFu1DAQBmALUdGl8AIcIBfEyWHGduL4iKpCK1XqoVTiZk0Sh_Uqsbd29rD79M1qFzhysjT6Zkaen7EPCCUC1l83ZTt1YykAsQRRAqhXbIWqVlwqqF6zFZgaeGPUr0v2NucNACpQ6g27FChN3WC1Yv1d78LsB9_R7GMoKPRF3M5-8odTIQ7F7OZE632fIhe3XPLWhQMd3NYHLngMLheUi_y8o9EFV-R9mNeUXeHD2rd-jim_YxcDjdm9P79X7On7zc_rW37_8OPu-ts971SlZl612OuKpJToDGkla4kDNNpU6FpJBF0NptVtD41AJUwtlTZ9s0itEaiXV-zLae42xeedy7OdfO7cOFJwcZdto48fbyT-X9aA2gCKRYqT7FLMObnBbpOfKO0tgj3GYDf2GIM9xmBB2CWGpenjefyunVz_t-XP3Rfw-QwodzQOiULn8z-nwCAiLO7TyQ0ULf1Oi3l6XDZVS5ZS1UbLF3udme4</recordid><startdate>20110415</startdate><enddate>20110415</enddate><creator>Griebenow, Nils</creator><creator>Flessner, Timo</creator><creator>Buchmueller, Anja</creator><creator>Raabe, Martin</creator><creator>Bischoff, Hilmar</creator><creator>Kolkhof, Peter</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20110415</creationdate><title>Identification and optimization of tetrahydro-2H-3-benzazepin-2-ones as squalene synthase inhibitors</title><author>Griebenow, Nils ; Flessner, Timo ; Buchmueller, Anja ; Raabe, Martin ; Bischoff, Hilmar ; Kolkhof, Peter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c454t-5b1d75a3331e9a743631f087951eb3aa0c609b7bd082142963479d8a747710ad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>alkyl (aryl) transferases</topic><topic>Animals</topic><topic>Benzazepines - chemical synthesis</topic><topic>Benzazepines - chemistry</topic><topic>Benzazepines - pharmacokinetics</topic><topic>Biological and medical sciences</topic><topic>Crystallography, X-Ray</topic><topic>enzyme inhibitors</topic><topic>Enzyme Inhibitors - chemical synthesis</topic><topic>Enzyme Inhibitors - chemistry</topic><topic>Enzyme Inhibitors - pharmacokinetics</topic><topic>Farnesyl-Diphosphate Farnesyltransferase - antagonists & inhibitors</topic><topic>Farnesyl-Diphosphate Farnesyltransferase - metabolism</topic><topic>General and cellular metabolism. Vitamins</topic><topic>heterocyclic compounds</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Microsomes, Liver - metabolism</topic><topic>Molecular Conformation</topic><topic>Pharmacology. Drug treatments</topic><topic>Stereoisomerism</topic><topic>Structure-Activity Relationship</topic><topic>structure-activity relationships</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Griebenow, Nils</creatorcontrib><creatorcontrib>Flessner, Timo</creatorcontrib><creatorcontrib>Buchmueller, Anja</creatorcontrib><creatorcontrib>Raabe, Martin</creatorcontrib><creatorcontrib>Bischoff, Hilmar</creatorcontrib><creatorcontrib>Kolkhof, Peter</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Bioorganic & medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Griebenow, Nils</au><au>Flessner, Timo</au><au>Buchmueller, Anja</au><au>Raabe, Martin</au><au>Bischoff, Hilmar</au><au>Kolkhof, Peter</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification and optimization of tetrahydro-2H-3-benzazepin-2-ones as squalene synthase inhibitors</atitle><jtitle>Bioorganic & medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2011-04-15</date><risdate>2011</risdate><volume>21</volume><issue>8</issue><spage>2554</spage><epage>2558</epage><pages>2554-2558</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>Novel squalene synthase inhibitors are disclosed. SAR and pharmacological profile of selected compounds are discussed.</abstract><cop>Amsterdam</cop><pub>Elsevier Ltd</pub><pmid>21396815</pmid><doi>10.1016/j.bmcl.2011.02.004</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0960-894X |
ispartof | Bioorganic & medicinal chemistry letters, 2011-04, Vol.21 (8), p.2554-2558 |
issn | 0960-894X 1464-3405 |
language | eng |
recordid | cdi_proquest_miscellaneous_872139831 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | alkyl (aryl) transferases Animals Benzazepines - chemical synthesis Benzazepines - chemistry Benzazepines - pharmacokinetics Biological and medical sciences Crystallography, X-Ray enzyme inhibitors Enzyme Inhibitors - chemical synthesis Enzyme Inhibitors - chemistry Enzyme Inhibitors - pharmacokinetics Farnesyl-Diphosphate Farnesyltransferase - antagonists & inhibitors Farnesyl-Diphosphate Farnesyltransferase - metabolism General and cellular metabolism. Vitamins heterocyclic compounds Humans Medical sciences Mice Microsomes, Liver - metabolism Molecular Conformation Pharmacology. Drug treatments Stereoisomerism Structure-Activity Relationship structure-activity relationships |
title | Identification and optimization of tetrahydro-2H-3-benzazepin-2-ones as squalene synthase inhibitors |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T20%3A04%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20and%20optimization%20of%20tetrahydro-2H-3-benzazepin-2-ones%20as%20squalene%20synthase%20inhibitors&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Griebenow,%20Nils&rft.date=2011-04-15&rft.volume=21&rft.issue=8&rft.spage=2554&rft.epage=2558&rft.pages=2554-2558&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2011.02.004&rft_dat=%3Cproquest_cross%3E860179012%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=860179012&rft_id=info:pmid/21396815&rfr_iscdi=true |